HBD-3 induces NK cell activation, IFN-γ secretion and mDC dependent cytolytic function

Area of Science:

• Immunology
• Innate Immunity
• Cellular Interactions

Background:

• Human beta defensin-3 (hBD-3) is known to activate myeloid dendritic cells (mDCs) through Toll-like receptor 1/2 (TLR1/2).
• The specific effects of hBD-3 on natural killer (NK) cells, crucial components of the innate immune system, were not fully elucidated.

Purpose of the Study:

• To investigate the direct and indirect effects of hBD-3 on NK cell activation and effector functions.
• To determine the role of TLR1/2 and C-C chemokine receptor type 2 (CCR2) in hBD-3 mediated NK cell responses.

Main Methods:

• Experiments involved peripheral blood mononuclear cells (PBMCs) and purified NK cells treated with hBD-3.
• NK cell activation was assessed by measuring interferon-gamma (IFN-γ) secretion and CD69 upregulation.
• Cytolytic activity against K562 and HUH hepatoma target cells was evaluated.
• Expression of TLR1, TLR2, and CCR2 on NK cells was analyzed.

Main Results:

• hBD-3 induced IFN-γ secretion and enhanced NK cell-dependent killing of target cells.
• Both TLR1/2 and CCR2 pathways were implicated in hBD-3's effects on PBMCs.
• hBD-3 directly activated purified NK cells, leading to CD69 upregulation and IFN-γ production.
• hBD-3 in combination with mDCs further augmented NK cell cytolytic activity and IFN-γ production.

Conclusions:

• hBD-3 directly activates NK cells, enhancing their effector functions such as cytotoxicity and cytokine secretion.
• hBD-3 also promotes mDC-mediated NK cell activity, suggesting a role in cell-cell communication.
• These findings highlight hBD-3 as a potential mediator bridging innate and adaptive immunity through interactions with dendritic cells and NK cells.